28 employees
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
1989
$4.3M
from 1 investors over 1 rounds
Idera Pharmaceuticals raised $4.3M on January 19, 2010
Investors: Merck Group